Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:CORV Correvio Pharma (CORV) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Correvio Pharma Stock (NASDAQ:CORV) 30 days 90 days 365 days Advanced Chart Ad Porter & CompanyWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. Get Correvio Pharma alerts:Sign Up Key Stats Today's Range$0.42▼$0.4250-Day Range$0.39▼$0.4252-Week Range$0.21▼$2.79VolumeN/AAverage Volume5.35 million shsMarket Capitalization$27.80 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewCorrevio Pharma Corp., a specialty pharmaceutical company, engages in developing therapeutics worldwide. Its portfolio of marketed brands comprise Aggrastat (tirofiban hydrochloride) for patients with acute coronary syndrome; and Brinavess (vernakalant IV) for the rapid conversion of recent onset atrial fibrillation to sinus rhythm. The company also offers ESMOCARD and ESMOCARD LYO, a short acting beta blocker for the treatment of supraventricular tachycardia and control of the ventricular rate in patients with atrial fibrillation; Trevyent, a development stage drug/device combination product for pulmonary arterial hypertension; Xydalba, a treatment for acute bacterial skin and skin structure infections; and Zevtera/Mabelio, a cephalosporin antibiotic for intravenous administration with rapid bactericidal activity. Correvio Pharma Corp. was incorporated in 2018 and is headquartered in Vancouver, Canada.Read More… Watch this before it gets removed (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. Receive CORV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Correvio Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address CORV Stock News HeadlinesCoriolis Pharma Launches New U.S. Entity and Platform ServicesOctober 22 at 10:47 PM | markets.businessinsider.comIs Corbus Pharmaceuticals Holdings, Inc. (CRBP) the Best Russell 2000 Stock to Buy According to Analysts?October 3, 2024 | msn.com2024's Must-Watch Stocks!Welcome to a year of unparalleled opportunities! Dive into our exclusive guide, "9 Stocks Set to Soar," meticulously selected to elevate your portfolio in 2024. Step into 2024 with confidence and the right assets at your fingertips. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time. October 24, 2024 | Darwin (Ad)Spotlight on Corbus Pharmaceuticals: Analyzing the Surge in Options ActivitySeptember 23, 2024 | benzinga.comCorbus Pharma (CRBP) Stock Drops 60% After Novo Nordisk's Cannabinoid-Based Weight Loss Drug Trial DisappointsSeptember 20, 2024 | benzinga.comBuy Rating Affirmed for Corbus Pharmaceuticals Amid Promising Outlook for Novel Oral Weight Loss Therapy CRBP-913September 13, 2024 | markets.businessinsider.comMaxim Group Reaffirms Their Hold Rating on Reviva Pharmaceuticals Holdings (RVPH)September 6, 2024 | markets.businessinsider.comCorbus Pharmaceuticals Holdings, Inc. (CRBP): This Small-Cap Healthcare Stock Is A Good Buy Right NowSeptember 5, 2024 | msn.comSee More Headlines CORV Stock Analysis - Frequently Asked Questions How were Correvio Pharma's earnings last quarter? Correvio Pharma Corp (NASDAQ:CORV) released its quarterly earnings results on Monday, March, 30th. The company reported ($0.07) earnings per share for the quarter, beating analysts' consensus estimates of ($0.13) by $0.06. The business earned $11.33 million during the quarter, compared to analyst estimates of $11.52 million. Correvio Pharma had a negative net margin of 107.81% and a negative trailing twelve-month return on equity of 2,128.82%. What other stocks do shareholders of Correvio Pharma own? Based on aggregate information from My MarketBeat watchlists, some other companies that Correvio Pharma investors own include Inovio Pharmaceuticals (INO), NightHawk Biosciences (NHWK), SCYNEXIS (SCYX), Acasti Pharma (ACST), Onconova Therapeutics (ONTX), Outlook Therapeutics (OTLK) and Vaxart (VXRT). Company Calendar Last Earnings3/30/2020Today10/24/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:CORV CUSIPN/A CIKN/A Webwww.correvio.com Phone604-677-6905FaxN/AEmployees133Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.79) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-35,180,000.00 Net Margins-107.81% Pretax MarginN/A Return on Equity-2,128.82% Return on Assets-58.56% Debt Debt-to-Equity Ratio22.54 Current Ratio1.07 Quick Ratio0.95 Sales & Book Value Annual Sales$32.63 million Price / Sales0.85 Cash FlowN/A Price / Cash FlowN/A Book Value($0.02) per share Price / Book-21.00Miscellaneous Outstanding Shares66,191,000Free FloatN/AMarket Cap$27.80 million OptionableOptionable Beta0.08 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report This page (NASDAQ:CORV) was last updated on 10/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonPorter & Company | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredGoldman Sachs’ AI warningAfter warning of last year's historic bank run, weeks in advance... Legendary stock-picker Marc Chaikin jus...Chaikin Analytics | SponsoredAmerica’s Election NightmareThanks to a new law signed by President Biden, a small group of powerful people could decide who is installed ...Banyan Hill Publishing | SponsoredIt’s delivered 859% in 2.5 months…We’ve gotten a lot of messages asking… what should we buy if Trump wins? What should we buy if Kamala wins?...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Correvio Pharma Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Correvio Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.